← vista completa

Publicado el 1 de enero de 2005 | http://doi.org/10.5867/medwave.2006.01.2317

Avances en feocromocitoma (II): diagnóstico

Advances in pheochromocytoma (II): Diagnosis

Rodrigo Tagle

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Rodrigo Tagle

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Tagle R. Advances in pheochromocytoma (II): Diagnosis. Medwave 2006;6(01):e2317 doi: 10.5867/medwave.2006.01.2317

Publicación 01/01/2006

Métricas del artículo

Artículo no tiene métricas.

Notas

Referencias

  1. Guyton AC. Textbook of Medical Physiology. Philadelphia: Saunders, 1981.
  2. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003 Aug;24(4):539-53. | CrossRef | PubMed
  3. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol. 1978 Mar;234(3):E252-6. | PubMed
  4. Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med. 1979 Sep 27;301(13):682-6. | CrossRef | PubMed
  5. Streeten DH. Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens. 1996 Aug;9(8):760-9. | CrossRef | PubMed
  6. Prokocimer PG. Maze M. Hoffman BB. Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma. J Pharmacol Exp Ther. 1987 Jun;241(3):870-4. | PubMed
  7. Johnson MD, Smith PG, Mills E, Schanberg SM. Paradoxical elevation of sympathetic activity during catecholamine infusion in rats. J Pharmacol Exp Ther. 1983 Oct;227(1):254-9. | PubMed
  8. Kinney MA, Warner ME, vanHeerden JA, Horlocker TT, Young WF Jr, Schroeder DR, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000 Nov;91(5):1118-23. | PubMed
  9. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur BJ. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998 Jun;83(6):2175-85. http://dx.doi.org/10.1210/jc.83.6.2175 | PubMed
  10. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003 Feb;88(2):553-8. | CrossRef | PubMed
  11. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best? JAMA. 2002 Mar 20;287(11):1427-34. | CrossRef | PubMed
  12. Mannelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol. 1999 Dec;141(6):619-24. | CrossRef | PubMed
  13. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, et al. Superiority of 6-[18F]-Fluorodopamine Positron Emission Tomography Versus [131I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma. J Clin Endocrinol Metab. 2003 Sep;88(9):4083-7. | CrossRef | PubMed
  14. Ilias I, Pacak K. Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma. J Clin Endocrinol Metab. 2004 Feb;89(2):479-91. | PubMed
  15. Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest. 1997 Dec;20(11):648-58. | PubMed
  16. Troncone L. Rufini V. Nuclear medicine therapy of pheochromocytoma and paraganglioma. Q J Nucl Med. 1999 Dec;43(4):344-55. | PubMed
  17. Rose B, Matthay KK, Price D, Huberty J, Klencke B, Norton JA, et al. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer. 2003 Jul 15;98(2):239-48. | CrossRef | PubMed